Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Malvern adds new Mastersizer and Zetasizer products

With its recent acquisitions the company has a rapidly growing portfolio of analytical solutions for pharma and biopharma applications

Europe | Measurement and Analysis

Ampac adds Flexi FoilFree HB Ultra High barrier film to portfolio

Provides moisture, oxygen and vapour barrier properties approaching those of aluminium foil

Packaging | North America

Do not delay and pay the hard way

Former AstraZeneca serialisation expert Christoph Krähenbühl demystifies the arguments around compliance with the forthcoming Safety Features regulations in the EU Falsified Medicines Directive, and questions whether some countries are dangerously behind in their implementation strategies

Packaging | Regulatory

US NIH begins early human clinical trial of VSV Ebola vaccine

Vaccine candidate was developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory

North America | R and D

Employing new single-use technology in bioprocesses

There has been considerable progress in the application of single-use technologies in biopharmaceutical production. CMO Rentschler Biotechnologie discusses recent advances

Europe | Biotechnology | Manufacturing

New drug could help in battle against cervical cancer

University of Leicester academic leads study into effects of cediranib drug in chemotherapy treatment of cervical cancer

Europe | R and D | Therapeutic Sector

Lyophilisation: meeting new demand and challenges

Armin Dalluege, General Manager of Wasserburger Arzneimittelwerk, a subsidiary of Recipharm, in Wasserburg, Germany, highlights trends in drug lyophilisation


The growth of mPEG technology

With an increase in the number of innovator companies looking to outsource the development and manufacture of mPEGs, Dr. Reddy’s (CPS) discusses what to look for in a potential outsourcing partner

Drug Delivery | R and D | Biotechnology | Manufacturing

Cloud-based eTMFs – less paper, more value

With regulatory pressure mounting, pharma companies should need no help deciding to migrate to paperless trial master files. For those thinking about switching, Rik van Mol, Vice President of R&D Strategy, Veeva Systems, outlines the key considerations for making the transition

Information Technology

In the Press